HEADER HYDROLASE/HYDROLASE INHIBITOR 23-OCT-00 1G37 TITLE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND TITLE 2 EXOSITE-DIRECTED PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA THROMBIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: COAGULATION FACTOR II; COMPND 5 EC: 3.4.21.5; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THROMBIN NONAPEPTIDE INHIBITOR; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 OTHER_DETAILS: THROMBIN PURCHASED FROM HAEMATOLOGIC TECHNOLOGIES; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES KEYWDS PROTEASE, THROMBIN, INHIBITOR, BLOOD CLOTTING, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.BACHAND,M.TARAZI,Y.ST-DENIS,J.J.EDMUNDS,P.D.WINOCOUR,L.LEBLOND, AUTHOR 2 M.A.SIDDIQUI REVDAT 5 06-NOV-24 1G37 1 REMARK REVDAT 4 09-AUG-23 1G37 1 REMARK LINK REVDAT 3 13-JUL-11 1G37 1 VERSN REVDAT 2 24-FEB-09 1G37 1 VERSN REVDAT 1 21-APR-01 1G37 0 JRNL AUTH B.BACHAND,M.TARAZI,Y.ST-DENIS,J.J.EDMUNDS,P.D.WINOCOUR, JRNL AUTH 2 L.LEBLOND,M.A.SIDDIQUI JRNL TITL POTENT AND SELECTIVE BICYCLIC LACTAM INHIBITORS OF THROMBIN. JRNL TITL 2 PART 4: TRANSITION STATE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 11 287 2001 JRNL REFN ISSN 0960-894X JRNL PMID 11212093 JRNL DOI 10.1016/S0960-894X(00)00636-3 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23917 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2387 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2323 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G37 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1000012176. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-APR-97 REMARK 200 TEMPERATURE (KELVIN) : 296.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24483 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.19600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS WITH OTHER REMARK 200 THROMBIN COMPLEXES REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1IHS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM PHOSPHATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP AT 296K, TEMPERATURE 296.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.72500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.01500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.72500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.01500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE MOLECULE ACTS AS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 14L REMARK 465 GLY A 14M REMARK 465 ARG A 15 REMARK 465 TRP A 147A REMARK 465 THR A 147B REMARK 465 ALA A 147C REMARK 465 ASN A 147D REMARK 465 VAL A 147E REMARK 465 GLY A 147F REMARK 465 LYS A 147G REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD1 HIS A 91 H ARG A 93 1.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HH21 ARG A 75 HH21 ARG A 75 2555 1.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 137 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 137 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -82.30 -126.38 REMARK 500 TYR A 60A 80.73 -153.48 REMARK 500 ASN A 60G 83.19 -159.68 REMARK 500 HIS A 71 -55.13 -128.53 REMARK 500 SER A 115 -168.66 -161.48 REMARK 500 GLU B 362 33.27 -73.78 REMARK 500 TYR B 363 -30.37 -145.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 110 A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF THROMBIN NONAPEPTIDE REMARK 800 INHIBITOR DBREF 1G37 A 1B 245 UNP P00734 THRB_HUMAN 334 620 DBREF 1G37 B 356 364 PDB 1G37 1G37 356 364 SEQRES 1 A 287 ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER SEQRES 2 A 287 LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR SEQRES 3 A 287 ILE ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU ILE SEQRES 4 A 287 GLY MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SER SEQRES 5 A 287 PRO GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER ASP SEQRES 6 A 287 ARG TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR PRO SEQRES 7 A 287 PRO TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU VAL SEQRES 8 A 287 ARG ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG ASN SEQRES 9 A 287 ILE GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE HIS SEQRES 10 A 287 PRO ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP ILE SEQRES 11 A 287 ALA LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER ASP SEQRES 12 A 287 TYR ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR ALA SEQRES 13 A 287 ALA SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL THR SEQRES 14 A 287 GLY TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN VAL SEQRES 15 A 287 GLY LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN LEU SEQRES 16 A 287 PRO ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR ARG SEQRES 17 A 287 ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR LYS SEQRES 18 A 287 PRO ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY ASP SEQRES 19 A 287 SER GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN ASN SEQRES 20 A 287 ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU GLY SEQRES 21 A 287 CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS VAL SEQRES 22 A 287 PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP GLN SEQRES 23 A 287 PHE SEQRES 1 B 9 PHE GLU ALA ILE PRO ALA GLU TYR LEU HET 110 A 900 43 HETNAM 110 3-(4-AMINO-CYCLOHEXYL)-2-HYDROXY-3-[(4-OXO-2- HETNAM 2 110 PHENYLMETHANESULFONYL-1,2,3,4-TETRAHYDRO-PYRROLO[1,2- HETNAM 3 110 A]PYRAZINE-6-CARBONYL)-AMINO]-PROPIONIC ACID BUTYL HETNAM 4 110 ESTER HETSYN 110 BCH-10556 FORMUL 3 110 C28 H38 N4 O7 S FORMUL 4 HOH *81(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B TYR A 14J 1 9 HELIX 3 3 ALA A 55 CYS A 58 5 4 HELIX 4 4 PRO A 60B ASP A 60E 5 4 HELIX 5 5 THR A 60I ASN A 62 5 3 HELIX 6 6 ASP A 125 LEU A 130 1 9 HELIX 7 7 GLU A 164 ASP A 170 1 7 HELIX 8 8 LYS A 185 GLY A 186C 5 5 HELIX 9 9 LEU A 234 PHE A 245 1 12 SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 PRO A 161 -1 N VAL A 157 O SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160 SHEET 4 A 7 PRO A 198 LYS A 202 -1 O PRO A 198 N THR A 139 SHEET 5 A 7 TRP A 207 TRP A 215 -1 N TYR A 208 O MET A 201 SHEET 6 A 7 GLY A 226 HIS A 230 -1 N PHE A 227 O TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228 SHEET 1 B 7 GLN A 30 ARG A 35 0 SHEET 2 B 7 GLU A 39 LEU A 46 -1 O GLU A 39 N ARG A 35 SHEET 3 B 7 TRP A 51 THR A 54 -1 N LEU A 53 O SER A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107 SHEET 6 B 7 LEU A 64 ILE A 68 -1 O LEU A 64 N LEU A 85 SHEET 7 B 7 GLN A 30 ARG A 35 -1 N MET A 32 O ARG A 67 SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.00 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.01 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.05 LINK OG SER A 195 C3 110 A 900 1555 1555 1.44 CISPEP 1 SER A 36A PRO A 37 0 -0.96 SITE 1 AC1 21 LEU A 40 LEU A 41 HIS A 57 TYR A 60A SITE 2 AC1 21 TRP A 60D GLU A 97A ASN A 98 ILE A 174 SITE 3 AC1 21 ASP A 189 ALA A 190 CYS A 191 GLU A 192 SITE 4 AC1 21 GLY A 193 ASP A 194 SER A 195 SER A 214 SITE 5 AC1 21 TRP A 215 GLY A 216 GLY A 219 HOH A 423 SITE 6 AC1 21 HOH A 478 SITE 1 AC2 8 PHE A 34 LYS A 36 GLN A 38 ARG A 67 SITE 2 AC2 8 ARG A 73 THR A 74 ARG A 75 TYR A 76 CRYST1 71.450 72.030 73.150 90.00 100.71 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013996 0.000000 0.002647 0.00000 SCALE2 0.000000 0.013883 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013913 0.00000 CONECT 23 1480 CONECT 532 677 CONECT 677 532 CONECT 1480 23 CONECT 1915 2063 CONECT 2063 1915 CONECT 2189 2469 CONECT 2220 2890 CONECT 2469 2189 CONECT 2852 2853 2859 2892 CONECT 2853 2852 2883 2890 CONECT 2854 2855 2857 CONECT 2855 2854 2856 CONECT 2856 2855 2881 CONECT 2857 2854 2858 2890 CONECT 2858 2857 CONECT 2859 2852 2860 2864 CONECT 2860 2859 CONECT 2861 2862 2865 CONECT 2862 2861 2863 2879 CONECT 2863 2862 2864 2867 CONECT 2864 2859 2863 2865 CONECT 2865 2861 2864 CONECT 2866 2867 2880 CONECT 2867 2863 2866 2878 CONECT 2868 2869 2870 2873 2880 CONECT 2869 2868 CONECT 2870 2868 CONECT 2871 2872 2877 CONECT 2872 2871 2873 2874 CONECT 2873 2868 2872 CONECT 2874 2872 2875 CONECT 2875 2874 2876 CONECT 2876 2875 2877 CONECT 2877 2871 2876 CONECT 2878 2867 CONECT 2879 2862 2880 CONECT 2880 2866 2868 2879 CONECT 2881 2856 2882 CONECT 2882 2881 CONECT 2883 2853 2884 2889 CONECT 2884 2883 2885 CONECT 2885 2884 2886 CONECT 2886 2885 2887 2888 CONECT 2887 2886 2893 2894 CONECT 2888 2886 2889 CONECT 2889 2883 2888 CONECT 2890 2220 2853 2857 2891 CONECT 2891 2890 CONECT 2892 2852 CONECT 2893 2887 CONECT 2894 2887 MASTER 306 0 1 9 14 0 8 6 2444 2 52 24 END